Drug-eluting stent outcomes in diabetes

Chiara Bernelli, Jaclyn Chan, Alaide Chieffo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.

Original languageEnglish
Pages (from-to)95-109
Number of pages15
JournalExpert Review of Cardiovascular Therapy
Volume12
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Drug-Eluting Stents
Percutaneous Coronary Intervention
Population
Drug Therapy
Equipment and Supplies

Keywords

  • coronary artery disease
  • coronary stents
  • diabetes mellitus
  • drug-eluting stents
  • outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine

Cite this

Drug-eluting stent outcomes in diabetes. / Bernelli, Chiara; Chan, Jaclyn; Chieffo, Alaide.

In: Expert Review of Cardiovascular Therapy, Vol. 12, No. 1, 01.2014, p. 95-109.

Research output: Contribution to journalArticle

Bernelli, Chiara ; Chan, Jaclyn ; Chieffo, Alaide. / Drug-eluting stent outcomes in diabetes. In: Expert Review of Cardiovascular Therapy. 2014 ; Vol. 12, No. 1. pp. 95-109.
@article{82b9942a74a0414d889fcdec4be3fc76,
title = "Drug-eluting stent outcomes in diabetes",
abstract = "Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.",
keywords = "coronary artery disease, coronary stents, diabetes mellitus, drug-eluting stents, outcomes",
author = "Chiara Bernelli and Jaclyn Chan and Alaide Chieffo",
year = "2014",
month = "1",
doi = "10.1586/14779072.2014.853615",
language = "English",
volume = "12",
pages = "95--109",
journal = "Expert Review of Cardiovascular Therapy",
issn = "1477-9072",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Drug-eluting stent outcomes in diabetes

AU - Bernelli, Chiara

AU - Chan, Jaclyn

AU - Chieffo, Alaide

PY - 2014/1

Y1 - 2014/1

N2 - Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.

AB - Diabetic population still remains a challenging subgroup of patients for percutaneous coronary intervention (PCI). However, with rapid advancements of PCI techniques, devices and adjunctive drug therapy, clinical outcomes for diabetic patients after PCI have markedly improved. The plethora of recent encouraging data with newer generation drug-eluting stent (DES), with a lower frequency of major cardiac adverse events, lead to an increasing use of DES in this particular high-risk population. However, diabetes remains an important risk factor for coronary events, even in the DES era. This review summarizes the outcomes in diabetic patients undergoing PCI with DES implantation.

KW - coronary artery disease

KW - coronary stents

KW - diabetes mellitus

KW - drug-eluting stents

KW - outcomes

UR - http://www.scopus.com/inward/record.url?scp=84893149823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893149823&partnerID=8YFLogxK

U2 - 10.1586/14779072.2014.853615

DO - 10.1586/14779072.2014.853615

M3 - Article

C2 - 24345095

AN - SCOPUS:84893149823

VL - 12

SP - 95

EP - 109

JO - Expert Review of Cardiovascular Therapy

JF - Expert Review of Cardiovascular Therapy

SN - 1477-9072

IS - 1

ER -